ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has coverage initiated with a Outperform rating and $60.00 price target

Analyst Ratings For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Story continues below

Today, Royal Bank of Canada initiated coverage on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with a Outperform with a price target of $60.00.

There are 11 Buy Ratings, 2 Hold Ratings, 1 Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is Buy with a consensus target price of $49.4286 per share, a potential 37.34% upside.

Some recent analyst ratings include

  • 10/1/2019-ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has coverage initiated with a Outperform rating and $60.00 price target
  • 9/13/2019-ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gets upgraded to Outperform by Svb Leerink with a price target of $50.00
  • 9/13/2019-ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gets upgraded to Outperform by Leerink Swann with a price target of $50.00
  • 9/10/2019-ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Buy rating reiterated by JPMorgan Chase & Co.
  • 9/10/2019-ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gets upgraded to Buy by Canaccord Genuity with a price target of $50.00
  • On 9/20/2019 Bros. Advisors Lp Baker, Director, bought 1,562,500 with an average share price of $40.00 per share and the total transaction amounting to $62,500,000.00.
  • On 9/11/2019 Eric Alejandro Miller, Insider, sold 4,645 with an average share price of $41.18 per share and the total transaction amounting to $191,281.10.
  • On 9/9/2019 Eric Alejandro Miller, Insider, sold 28,467 with an average share price of $39.49 per share and the total transaction amounting to $1,124,161.83.
  • On 9/9/2019 James M Daly, Director, sold 30,000 with an average share price of $37.80 per share and the total transaction amounting to $1,134,000.00.
  • On 1/9/2019 Laura Brege, Director, sold 10,000 with an average share price of $20.00 per share and the total transaction amounting to $200,000.00.
  • On 11/30/2018 Bros. Advisors Lp Baker, Director, bought 11,764,705 with an average share price of $17.00 per share and the total transaction amounting to $199,999,985.00.
  • On 9/20/2018 Bros. Advisors Lp Baker, Director, bought 1,210,776 with an average share price of $18.70 per share and the total transaction amounting to $22,641,511.20.

Recent Trading Activity for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Shares of ACADIA Pharmaceuticals Inc. closed the previous trading session at 35.99 −0.79 2.15% with 36.69 shares trading hands.

An ad to help with our costs